Cargando…
Analysis of Density Changes of Selected Brain Receptors After a 14-Day Supply of Chromium(III) and Evaluation of Chromium(III) Affinity to Selected Receptors and Transporters
Chromium(III) is one of the most controversial biometals. Although, it is no longer on the list of minerals necessary for the proper functioning of the human body, and its pharmacological effect is still under discussion. One of the purposes of Cr(III) administration is to use it in patients with mo...
Autores principales: | Piotrowska, Anna, Siwek, Agata, Wolak, Małgorzata, Nowak, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306032/ https://www.ncbi.nlm.nih.gov/pubmed/31732929 http://dx.doi.org/10.1007/s12011-019-01924-y |
Ejemplares similares
-
The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
por: Piotrowska, Anna, et al.
Publicado: (2019) -
Chromium(III) and DNA damage.
por: Beyersmann, D
Publicado: (2001) -
Chromium released from leather – I: exposure conditions that govern the release of chromium(III) and chromium(VI)
por: Hedberg, Yolanda S, et al.
Publicado: (2015) -
Chromium(III), chromium(VI) and cobalt release from leathers produced in Nicaragua
por: Hedberg, Yolanda S., et al.
Publicado: (2018) -
Preparation of anthracene-based tetraperimidine hexafluorophosphate and selective recognition of chromium(III) ions
por: Liu, Qing-Xiang, et al.
Publicado: (2019)